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Abstract
Acute central nervous system (CNS) infections in children in sub-Saharan Africa are often
fatal. Potential contributors include late presentation, limited diagnostic capacity and inade-
quate treatment. A more nuanced understanding of treatment practices with a goal of opti-
mizing such practices is critical to prevent avoidable case fatality. We describe empiric
antimicrobial treatment, antibiotic resistance and treatment adequacy in a prospective
cohort of 459 children aged two months to 12 years hospitalised for suspected acute CNS
infections in Mbarara, Uganda, from 2009 to 2012. Among these 459 children, 155 had a
laboratory-confirmed diagnosis of malaria (case-fatality rate [CFR] 14%), 58 had bacterial
infections (CFR 24%) and 6 children had mixed malaria and bacterial infections (CFR 17%).
Overall case fatality was 18.1% (n = 83). Of 219 children with laboratory-confirmed malaria
and/or bacterial infections, 182 (83.1%) received an adequate antimalarial and/or antibiotic
on the day of admission and 211 (96.3%) within 48 hours of admission. The proportion of
those receiving adequate treatment was similar among survivors and non-survivors. All
bacterial isolates were sensitive to ceftriaxone except one Escherichia coli isolate with
extended-spectrum beta-lactamase (ESBL). The observed high mortality was not a result of
inadequate initial antimicrobial treatment at the hospital. The epidemiology of CNS infection
in this setting justifies empirical use of a third-generation cephalosporin, however antibiotic
resistance should be monitored closely.
Introduction
Acute infections of the central nervous system (CNS) in children are usually severe and associ-
ated with high case fatality rates (CFR; 10–35%). Up to 15% have major neurological sequelae
[1–3]. Late and/or inadequate treatment of bacterial meningitis is associated with poor
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outcome [4,5]. To reduce such outcomes, CNS infections should be treated with an appropri-
ate antimicrobial agent as early as possible [6]. Empiric antibiotic treatment is the standard of
care for suspected bacterial CNS infections before the pathogen and its sensitivity to antimi-
crobials are confirmed by laboratory diagnosis. Inadequate treatment can result from antibi-
otic resistance or from inappropriate antibiotic choice for drug-sensitive bacterial infections.
In sub-Saharan Africa, factors associated with high CFR of CNS infections include subopti-
mal health care access and late presentation [7]. Furthermore, the clinical diagnosis of bacterial
meningitis is particularly challenging given the high prevalence of other infections presenting
with a similar clinical picture, such as cerebral malaria. In rural areas, health workers first con-
sulted are often of a lower cadre and require critical supervision to differentiate between com-
peting diagnoses [8,9]. Underutilization of lumbar puncture and poor access to microbiology
services in many low-income countries contribute to poor knowledge of the local aetiology of
bacterial meningitis and antibiotic resistance patterns [10].
Confronted with high mortality, especially within the first 48 hours of admission, clinicians
in low income countries rely on empiric antimicrobial treatment for the management of chil-
dren with suspected CNS infections, a strategy that is increasingly threatened by reduced anti-
microbial susceptibility. Here we describe empiric antimicrobial treatment practices,
antibiotic resistance and treatment adequacy in children with abnormal CNS symptoms and
signs in the presence of bacterial or malaria infection in a regional referral hospital in Mbarara,
Uganda. We focus on malaria and bacterial infections because of the limited ability to diagnose
and assess treatment for viral infections. This is a secondary analysis of data collected within a
study of the aetiology of suspected CNS infections published elsewhere [11].
Materials and methods
Study population
The study took place in two hospitals, Mbarara Regional Referral Hospital (MRRH) and Holy
Innocents Children’s hospital (HICH) in Mbarara, located 300 km south-west of the capital
Kampala. The prevalence of malaria in the Mbarara district ranges from 3% in urban areas to
23% in rural areas during the rainy season [12].Children between two months and 12 years
admitted with suspicion of acute CNS infection based on fever or history of fever in the past 48
hours and recent onset of at least one sign of CNS involvement. CNS symptoms and signs
included: non-traumatic reduced level of consciousness, prostration, hypertonia/hypotonia,
irritability, severe headache, photophobia, neck stiffness, bulging fontanelle, prolonged sei-
zures, focal neurological signs, purpura or Cheyne stokes breathing. Children who met the cri-
teria above were enrolled into a prospective descriptive cohort study between August 2009 and
October 2012. A more complete description of the study population and methods is provided
elsewhere [11].
Clinical and laboratory investigations
Socio-demographic and clinical characteristics of the participants including age, gender, HIV
exposure, history and type of previous treatment as well as clinical information at admission
and discharge and treatment received were recorded in a standardized case report form [11].
Diagnosis at admission was based on clinical examination and systematic testing with a rapid
diagnostic test for malaria (SD-Bioline Malaria Antigen P.f/Pan, Standard Diagnostics, Korea).
Final diagnosis was informed by biological investigations of blood and cerebrospinal fluid
(CSF). Sample collection was performed systematically upon inclusion. Venous blood samples
were collected aseptically into two single bottle blood-culture system (Signal Blood Culture
System, Oxoid) and into EDTA tubes for hematological analyses. CSF was aseptically obtained
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by lumbar puncture into sterile CSF tubes. To diagnose bacterial pathogens, blood and CSF
were analyzed at the Epicentre research laboratory on site following standardized bacteriology
procedures [11]. Culture, staining, biochemical testing were used to identify any bacterial
pathogens present. Drug susceptibility testing (DST) was done following the Comite´ De L’anti-
biogramme De La Socie´te´ Francaise De Microbiologie (CA-SASFM 2006) guidelines [13]. We
used the Kirby-Bauer disc diffusion method and E-tests to determine drug clearance zones
and minimum inhibitory concentrations (MICs), respectively.
In addition, real-time polymerase chain reaction (qPCR) was performed systematically on
CSF to look for the following bacterial pathogens: S. pneumoniae, H. influenzae type b (Hib),
Salmonella, Listeria monocytogenes, as well as viral pathogens not presented here. These qPCRs
were carried out initially at Epicentre Research Laboratory, Mbarara and later at APHM Labo-
ratory, Marseille, France, on CSF stored and transported at -80˚C following standardized pro-
cedures [11].
Thick and thin blood smears were prepared from EDTA blood, Giemsa-stained and exam-
ined by microscopy as recommended by the World Health Organization (WHO) to confirm
malaria infection [14].
Description of treatment guidelines
Patients were treated by the attending ward clinician according to the treatment protocols of
the pediatric wards of the MRRH and HICH, where the empiric treatment of meningitis is
benzyl penicillin (Penicillin G) at 50,000 IU/kg every 6 hours combined with ceftriaxone at a
dose of 100 mg/kg/day for 10–14 days modified according to results for culture or sensitivity.
Treatment for severe malaria changed in the course of the study (September 2011) from intra-
venous quinine to intravenous artesunate, 3mg/kg at hour 0, 12 and 24 for a minimum of 48
hours followed by oral artesunate/lumefantrine (20/120mg) for a total of 3 days once the child
can tolerate oral treatment [15]. There were no established hospital protocols to guide empiric
treatment for bacteremia or concomitant antibiotic treatment for severe malaria.
Definitions and data analysis
Bacterial meningitis was considered if a bacterial pathogen was detected in the CSF by culture,
qPCR or Gram staining, whereas bacteremia was concluded if a bacterial pathogen was
detected in blood but not in the CSF.
Empiric treatment was defined as the first treatment received after admission.
Adequate treatment was defined as treatment with antimalarial for a confirmed laboratory
diagnosis of malaria and/or at least one appropriate antibiotic for bacterial infection according
to the DST results (or extrapolated from overall DST results if DST results were not available
for a specific isolate)–regardless of the duration of treatment and possible over-treatment.
Insufficient treatment duration was defined as an antimalarial treatment given for less than
3 days or antibiotic treatment given for less than 5 days for bacteremia or 10 days for bacterial
meningitis, or for less than the number of days of hospitalization for those who died or were
discharged against medical advice before the recommended treatment duration.
Excessive treatment duration was defined as an antimalarial given for more than 8 days or
an antibiotic treatment given for more than 21 days for bacterial infections. The rationale for
21 days was to adequately treat for meningitic syndromes that require an extended treatment
period such as infections resulting from Enterobacteriaceae or Listeria monocytogenes.
Double data entry and data validation was done using EpiData Entry software (version 3.1,
EpiData Association, Odense, Denmark) and analysis was performed using Stata (version 12,
College Station, Texas, USA).
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Results were analyzed using descriptive statistics to obtain frequencies and proportions.
Differences between groups were tested at 5% significance level. The analysis of antimicrobial
treatment practices focused on children with a laboratory-confirmed malaria and/or bacterial
infections with CNS involvement.
Ethics
Ethical approval was obtained from Mbarara University Research and Ethics Committee
(MUIRC 1/7), the Uganda National Council for Science and Technology (HS 584) and the
Comite´ de Protection des Personnes, Ile de France XI, Saint-Germain en Laye France(refer-
ence 09013). Written informed consents for study participation were obtained from partici-
pants’ parents or legal guardians. All participants were provided with treatment free of charge.
The study was in accordance with the ethical standards of the Helsinki Declaration.
Results
Description of the study population
We describe results for 459 children among 480 children with suspected acute CNS infections
enrolled in the study (Fig 1); 20 children were excluded because they were enrolled 48 hours
Fig 1. Study flow-chart.
https://doi.org/10.1371/journal.pone.0205316.g001
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after admission, for a diagnosis at admission different from a suspected CNS infection and one
child was excluded because he had been included twice in one month.
Of the 459 children with suspected acute CNS infections, 291 (63.4%) were boys. The
median age was 30 months (interquartile range (IQR): 11–60). A significant proportion of
children presented with reduced consciousness (71.7%) and/or seizures on admission (51.9%).
Clinical characteristics at admission are presented in Table 1. Fifty-eight (12.6%) of the chil-
dren had been hospitalized elsewhere in the month before their admission, for a median dura-
tion of 2 days (IQR: 1–4).
The laboratory results confirmed a diagnosis of bacterial and/or malarial infection in 219
(47.7%) children. Malaria was the only confirmed pathogen for 155 (33.8%) children, of which
109 had a clinical diagnosis of cerebral malaria, while 58 (12.6%) children were diagnosed with
bacterial infections only, 47 of whom had meningitis; and 6 (1.3%) children had mixed bacte-
rial and malarial infections. Another 17 children had a virus detected in the CSF as a potential
co-infection with malaria (n = 5) or bacteria (n = 12) and are not included in the analysis of
treatment adequacy due to uncertainty on the etiological agent and lack of viral treatment.
Finally, 16 (3.5%) children had another type of infection (tuberculous meningitis, Cryptococ-
cus, and/or viruses) and 207 (45.1%) had no laboratory-confirmed diagnosis (more details in
[11]).
Overall, 83 children (18.1%) died at the hospital. Of these, over one third (n = 32, 38.6%)
died on the day of admission or the next day. There was no significant difference in the pro-
portion who died among those hospitalized in previous month (7/58, 12.1%) and those who
were not (76/401, 19.0%). Deaths within 48h of hospitalization were associated with symptoms
of severe illness including loss of consciousness, respiratory distress, abnormal lung ausculta-
tion or signs of shock (cold extremities and reduced capillary refill), while later deaths were
Table 1. Socio-demographic and clinical characteristics at inclusion of patients overall, survivors and non-survivors by delay between admission and death.
Total (N = 459) Survivors (N = 376) Non-survivors p-value
Died <48h (N = 32) Died48h (N = 51)
Patients characteristics
Male sex 291 (63.4) 233 (62.0) 23 (71.9) 35 (68.6) 0.38
Age (months) 0.63
2–11 122 (26.6) 95 (25.3) 10 (31.3) 17 (33.3)
12–59 221 (48.2) 187 (49.7) 13 (40.6) 21 (41.2)
 60 116 (25.3) 94 (25.0) 9 (28.1) 13 (25.5)
HIV-positive (N = 451) 44 (9.8) 28 (7.6) 3 (9.7) 13 (26.0) 0.001
Clinical characteristics at inclusion
Reduced consciousness 329 (71.7) 255 (67.8) 31 (96.9) 43 (84.3) <0.001
Seizures (N = 458) 238 (51.9) 192 (51.1) 21 (65.6) 25 (50.0) 0.284
Neck stiffness (N = 452) 100 (21.8) 75 (20.0) 4 (13.3) 21 (42.0) 0.002
Hepatomegaly 181 (39.4) 142 (37.8) 18 (56.3) 21 (41.2) 0.117
Splenomegaly 130 (28.3) 108 (28.7) 13 (40.6) 9 (17.7) 0.071
Respiratory distress 136 (29.6) 94 (25.0) 18 (56.3) 24 (47.1) <0.001
Dehydration 80 (17.4) 58 (15.4) 6 (18.8) 16 (31.4) 0.019
Abnormal lung auscultation 63 (13.7) 43 (11.4) 8 (25.0) 12 (23.5) 0.01
Delayed capillary refill 17 (3.7) 10 (2.7) 5 (15.6) 2 (3.9) 0.006
Cold extremities 20 (4.3) 12 (3.2) 4 (12.5) 4 (7.8) 0.019
Cyanosis 4 (0.9) 2 (0.5) 1 (3.1) 1 (2.0) 0.151
 p-value for the comparison between survivors, those who died before 48h and those who died at or after 48h.
https://doi.org/10.1371/journal.pone.0205316.t001
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associated with neck stiffness, dehydration and HIV/AIDS (Table 1). Case fatality was 22
(14.2%) for malaria cases, 14 (24.1%) for bacterial cases and 1 (16.7%) with both malaria and
bacterial infection.
Bacteria and antibiotic resistance
Among the 64 children with bacterial infections (including mixed bacterial and malaria infec-
tions), the pathogens most frequently isolated were Streptococcus pneumoniae, followed by
non-typhi Salmonella (NTS) and Haemophilus influenzae type b (Table 2). Eight children had
bacterial meningitis diagnosed based on Gram stain of the CSF; of these, 7 yielded Gram-posi-
tive diplococci suggestive of S. pneumoniae.
Twelve enterobacteria (7 NTS, 3 S. typhi, 2 E. coli) were tested for antibiotic resistance (Fig
1). Except for one E. coli with extended beta-lactamase activity (ESBL), the enterobacteria were
sensitive to ceftriaxone, but most were resistant to amoxicillin and cotrimoxazole and one
third to gentamicin (Fig 2). Notably, all three S. typhi were resistant to ofloxacin.
All isolates of S. pneumoniae tested for antibiotic resistance were sensitive to ceftriaxone
and amoxicillin, but 11/13 showed intermediate resistance to benzyl penicillin with a mean
MIC of 0.34 mg/L. The 4 Hib tested for antibiotic resistance were sensitive to amoxicillin-cla-
vulanic acid and ceftriaxone but 3 were resistant to amoxicillin.
Of the 58 patients who were hospitalized in the previous month, 14 had a bacterial infection
(6 Salmonella spp, 5 S. pneumoniae, 2 Hib, 1 E. coli) but none of these isolates were multidrug
resistant.
Treatments received
Overall, 48.1% (n = 221) of children with suspected CNS infection received antibiotics and/or
antimalarial treatment within seven days prior to admission at MRRH or HICH, of whom 42
received antibiotics only, 114 received antimalarials only, and 65 received both. The propor-
tion of patients having received any kind of medication in the seven days prior to admission
was higher among children hospitalized in the previous month (77.6% vs 52.1%, p<0.001) and
this applied both to antibiotics (39.3% vs 21.5%) and to antimalarials (57.1% vs 37.0%). The
main antibiotics received, alone or in combination, prior to admission were benzyl penicillin
(n = 44), ceftriaxone (n = 28) and cotrimoxazole (n = 18). The main antimalarials received
were quinine (intravenous n = 67, oral n = 36, or intramuscular n = 29) and artemether/lume-
frantrine (n = 42).
All but one child, who was rapidly referred to another hospital, received antimicrobial treat-
ment during admission. On the day of admission, 138 (30.1%) children received both
Table 2. Bacteria isolates from CSF or blood by culture and/or PCR.
Total CSF culture & PCR CSF PCR CSF culture Blood culture only
S. pneumoniae 34 12 15 2 5
Salmonella spp. 10 3 3 0 4
S. Typhi 3 1 0 0 2
H. influenzae 5 3 1 1 0
E. coli 2 0 0 0 2
S. epidemidis 1 0 0 0 1
Brevibacterium spp. 1 0 0 1 0
This table does not include 8 cases for which bacteria were observed in CSF by Gram staining
https://doi.org/10.1371/journal.pone.0205316.t002
Antimicrobial treatment practices for CNS infections in Ugandan children
PLOS ONE | https://doi.org/10.1371/journal.pone.0205316 October 9, 2018 6 / 12
antibiotics and antimalarial, 153 (33.3%) children received antibiotics only and 106 (23.1%)
antimalarial only. Within 48 hours of admission, an additional 92 children received antibiotics
and 39 children received antimalarials.
Among the 291 children who received empiric antibiotic treatment on the day of admis-
sion, the most common antibiotics received were ceftriaxone (n = 226, 77.7%) and benzyl pen-
icillin (n = 212, 72.9%), usually as a combination (n = 169, 58.1%). Among those given
antimalarial treatment on admission, most of the children (185/244, 75.8%) were treated with
quinine, followed by artesunate (n = 51).
Fig 2. Proportion of sensitive, intermediate and resistant isolates among enterobacteria, S. pneumoniae and Haemophilus influenzae type b isolated in the study.
https://doi.org/10.1371/journal.pone.0205316.g002
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Treatment adequacy
Of the 219 children with laboratory-confirmed bacterial and/or malaria infection, 182 (83.1%)
received adequate treatment on the day of admission, while 211 (96.3%) received adequate
treatment within 48 hours of admission (Table 1). In total, 8 children did not receive adequate
treatment within 48 hours of admission, of which two died. One child with ESBL-producing E.
coli resistant to ciprofloxacin received benzyl penicillin, ceftriaxone and ciprofloxacin within
24 hours of admission but died 48 hours after admission. The other child had a mixed malarial
and bacterial infection, was treated with only antimalarials and died within 24 hours of admis-
sion before blood culture result was available. There was no significant difference in the pro-
portion of those who received adequate antimalarial or antibiotic treatment at different time
points (prior to admission, on the day of admission, or within 2 days of admission) among sur-
vivors and non-survivors (Table 3).
Treatment duration
Of the 161 children who had malaria (including 6 with mixed malaria and bacterial infection),
9 (5.6%) children had an insufficient duration of treatment and 17 (10.6%) an excessive dura-
tion. Among 58 children with bacterial infections only, 7 (12.1%) had an insufficient duration
of treatment (5 to 8 days), while 6 (10.3%) had an excessive duration. Finally, 2 of 6 with mixed
malaria and bacterial infection had an insufficient duration of treatment.
Discussion
In the context of global rise in antibiotic resistance [16,17] and the absence of microbiology
capacity in most resource-limited settings (11), clinicians face uncertainty regarding the
appropriateness and efficacy of empirical treatments. This study of the aetiology of CNS infec-
tions in Mbarara provided us with an opportunity to investigate the adequacy of treatment
received by children admitted with bacterial or malaria infection. We found a high mortality
in children, particularly among those with bacterial CNS infection, in line with other findings
from Africa reporting in-hospital CRFs ranging from 9% to 67% for all types of confirmed bac-
terial meningitis [3] and from 18% to 94% for pneumococcal meningitis [18]. In the present
study, all meningitis deaths but two had received adequate treatment within 48h of admission,
suggesting that lack of adequate treatment in the hospital was not the main cause of the high
Table 3. Description of treatment received per type of infection and outcome.
Survivors Non survivors p-value
Malaria only N = 133 N = 22
Antimalarials prior admission (N = 153) 66 (51.6) 10 (45.5) 0.57
Antimalarials on admission 111 (83.5) 21 (95.5) 0.20
Antimalarials within 48h of admission 128 (96.3) 22 (100) 1
Bacterial infection only N = 44 N = 14
Adequate treatment prior admission (N = 53) 12 (30.0) 2 (15.4) 0.47
Adequate treatment on admission 36 (81.8) 12 (85.7) 1
Adequate treatment within 48h of admission 43 (97.7) 13 (92.9) 0.43
Mixed malaria and bacterial infection N = 5 N = 1
Adequate treatment prior admission 0 (0) 0 (0) /
Adequate treatment on admission 2 (40.0) 0 (0) 1
Adequate treatment within 48h of admission 5 (100) 0 (0) 0.17
https://doi.org/10.1371/journal.pone.0205316.t003
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mortality, while illustrating some of the main challenges for empiric treatment in these con-
texts: antibiotic resistance and co-infections.
The levels of antibiotic resistance among isolates found in this study was relatively low, in
line with Ugandan data reported in the 2014 Antimicrobial Resistance report published by
WHO [17]. Though reduced susceptibility of S. pneumoniae to benzyl penicillin was already
reported in children with pneumococcal meningitis in Uganda in 2005–2006 [19], no com-
plete resistance to penicillin has been observed here or elsewhere in this area [20]. Given the
antibiotic resistance patterns with reduced susceptibility to benzyl penicillin and presence of
enterobacteria as causative agents in some children, it is reasonable to use ceftriaxone or cefo-
taxime as first line management for acute meningitis in this region empirically, as recom-
mended in the Ugandan clinical guidelines [15]. However, one of the two children who died
without receiving adequate treatment was infected with an ESBL-producing multidrug resis-
tant E.coli isolate. This raises a concern as such infection is difficult to detect and active agents
against ESBL-producing gram-negatives, such as carbapenems, were not available on site for
treatment and remain largely unavailable in the African public sector. Hence, close monitoring
of the possible emergence of ESBL enterobacteria is warranted.
The other child who died without receiving adequate treatment had a mixed bacterial-
malaria infection but was treated for malaria only. The current WHO recommendation is to
administer broad-spectrum antibiotics to children with severe malaria until a bacterial infec-
tion is excluded [21]. However, these recommendations are debated considering the high prev-
alence of malaria and consequences of adding an antibiotic both in terms of cost and risk for
antibiotic resistance [22]. It also shows the need to develop rapid tests for identifying life-
threatening bacterial infections occurring with or without malaria.
Although the majority of children, including those who died, had received adequate treat-
ment within 48h of admission, the time of administration of antimicrobial treatment was not
optimal for all children. The delay in initiation of treatment could be due to delay in clinical
decision making by junior medical officers or drug shortages, as commonly seen in this con-
text. Refresher training and supervision of junior health workers and nursing staff to adhere to
treatment protocols could be helpful in ensuring prompt administration of antimicrobial treat-
ment. Indeed, almost one in five children did not receive adequate treatment on the day of
hospital admission. The proportions were similar in children who survived and died, suggest-
ing no direct association with increased risk of death, however there may be other factors
involved that could have obscured such a relationship.
We found both insufficient duration of antibiotics in some children and excessive duration
in others. Insufficient duration may place children at higher risk of death and of relapse, espe-
cially in low-resources settings where follow-up outpatient care systems are weak. Under-treat-
ment is also a concern with pathogens that are more difficult to eradicate including Salmonella
spp. [23]. Here, however, all children with insufficient duration of antibacterial treatment had
received at least 5 days of treatment, which was shown to be sufficient in most cases [24].
Over-treatment comes with other risks including the risk to patients of prolonged hospitaliza-
tion, elevated risk of treatment-related toxicity, inconvenience / loss of income for family and
the potential contribution to individual and community antibiotic resistance. Non-adherence
to treatment guidelines in humanitarian hospitals has been associated with poor outcomes
such as death or loss to follow up in pediatric patients [25].
One important limitation of this study was that we did not have data on duration of symp-
toms prior to seeking medical care or hospitalization; delayed presentations could have
resulted in increased mortality. We also did not have data on the precise time of treatment ini-
tiation upon presentation, although the majority of patients received treatment on the day of
admission. Another limitation was the inclusion of children with various clinical presentations
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at admission and types of infections, including cerebral and non-cerebral malaria, bacterial
meningitis and bacteremia with neurological symptoms, with different risks of death. How-
ever, this reflects the practical reality of clinical medicine in a pediatric hospital in Uganda.
Furthermore, the categorization of treatment adequacy is challenging and we did neither con-
sider treatment dosages nor the additional (non-antimicrobial) treatments received by the
children. Finally, this study was a secondary analysis of a pre-existing cohort and may not have
been adequately powered to detect differences in the outcomes of interest. Therefore, the find-
ings should be considered to be exploratory.
Despite these limitations, the data suggest that it is unlikely that the high in-hospital mortal-
ity observed in this study was due to inadequate initial antimicrobial treatment. Hence, we
speculate that some of the contributing factors could have been delay in presentation from
poor treatment access or late caregiver disease recognition, severity of disease or late adminis-
tration of the antimicrobial on the day of admission [26]. This highlights the need for better
recognition and management of severe febrile illnesses in the community. Given the high
prevalence of bacterial meningitis among children admitted with fever and suspicion of CNS
infection and local patterns of antibiotic susceptibility, the empirical use of a third-generation
cephalosporin on admission appears to be justified in this setting, but the evidence of emerging
resistance to cephalosporins among enterobacteria emphasizes the need for close monitoring
of antibiotic resistance.
Supporting information
S1 Dataset. Study dataset. All dates in the dataset were randomly modified to ensure data
anonymization.
(XLSX)
Acknowledgments
We would like to thank all participants in the study and their parents, and the study team in
the ward: Kalubi Peter, Jenifer Zungu, Dickson Tumusiime and Grace Kekirunga, Gervase
Ndyanabo, Kemigisa Rose, Amerias Arimpa, Masturah Nakanwagi and Doreen Mpeirwe; and
in the laboratory: Victoria Katawera, Sulaiman Muwanga, Daniel Omoding, Harriet Adrama,
Thadeous Tuhuro, Arnold Ayebare, Patrick Orikiriza and Celine Gazin.
Author Contributions
Conceptualization: Elizabeth Kemigisha, Anne-Laure Page, Juliet Mwanga-Amumpaire.
Data curation: Deborah Nanjebe, Yolanda Mueller, Anne-Laure Page.
Formal analysis: Elizabeth Kemigisha, Deborah Nanjebe, Yap Boum II, Ce´line Langendorf,
Said Aberrane, Fabienne Nackers, Yolanda Mueller, Anne-Laure Page, Juliet Mwanga-
Amumpaire.
Investigation: Elizabeth Kemigisha, Deborah Nanjebe, Yap Boum II, Said Aberrane, Dan Nye-
hangane, Re´mi Charrel, Anne-Laure Page, Juliet Mwanga-Amumpaire.
Methodology: Elizabeth Kemigisha, Yap Boum II, Ce´line Langendorf, Said Aberrane, Dan
Nyehangane, Fabienne Nackers, Re´mi Charrel, Richard A. Murphy, Anne-Laure Page,
Juliet Mwanga-Amumpaire.
Project administration: Fabienne Nackers, Anne-Laure Page, Juliet Mwanga-Amumpaire.
Resources: Anne-Laure Page.
Antimicrobial treatment practices for CNS infections in Ugandan children
PLOS ONE | https://doi.org/10.1371/journal.pone.0205316 October 9, 2018 10 / 12
Supervision: Anne-Laure Page, Juliet Mwanga-Amumpaire.
Validation: Ce´line Langendorf, Dan Nyehangane, Fabienne Nackers, Yolanda Mueller, Re´mi
Charrel, Richard A. Murphy, Anne-Laure Page.
Writing – original draft: Elizabeth Kemigisha, Deborah Nanjebe, Juliet Mwanga-
Amumpaire.
Writing – review & editing: Yap Boum II, Ce´line Langendorf, Said Aberrane, Dan Nyehan-
gane, Fabienne Nackers, Yolanda Mueller, Re´mi Charrel, Richard A. Murphy, Anne-Laure
Page.
References
1. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, et al. (2010) Artesunate versus quinine in
the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised
trial. The Lancet 376: 1647–1657.
2. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, et al. (2010) Global and regional risk of dis-
abling sequelae from bacterial meningitis: a systematic review and meta-analysis. The Lancet infectious
diseases 10: 317–328. https://doi.org/10.1016/S1473-3099(10)70048-7 PMID: 20417414
3. Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, et al. (2009) Sequelae due to bacterial
meningitis among African children: a systematic literature review. BMC medicine 7: 1. https://doi.org/
10.1186/1741-7015-7-1
4. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial
treatment of bloodstream infections on patient outcomes in the ICU setting. Chest Journal 118: 146–
155.
5. Kollef MH (2000) Inadequate antimicrobial treatment: an important determinant of outcome for hospital-
ized patients. Clinical infectious diseases 31: S131–S138. https://doi.org/10.1086/314079 PMID:
11017862
6. Aronin SI, Peduzzi P, Quagliarello VJ (1998) Community-acquired bacterial meningitis: risk stratification
for adverse clinical outcome and effect of antibiotic timing. Annals of internal medicine 129: 862–869.
PMID: 9867727
7. Proulx N, Frechette D, Toye B, Chan J, Kravcik S (2005) Delays in the administration of antibiotics are
associated with mortality from adult acute bacterial meningitis. Qjm 98: 291–298. https://doi.org/10.
1093/qjmed/hci047 PMID: 15760921
8. Rowe AK, de Savigny D, Lanata CF, Victora CG (2005) How can we achieve and maintain high-quality
performance of health workers in low-resource settings? The Lancet 366: 1026–1035.
9. Rowe AK, Onikpo F, Lama M, Osterholt DM, Rowe SY, et al. (2009) A multifaceted intervention to
improve health worker adherence to integrated management of childhood illness guidelines in Benin.
American journal of public health 99: 837–846. https://doi.org/10.2105/AJPH.2008.134411 PMID:
19299681
10. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA (2006) Laboratory medicine in Africa: a barrier
to effective health care. Clinical Infectious Diseases 42: 377–382. https://doi.org/10.1086/499363
PMID: 16392084
11. Page A-L, Yap Boum I, Kemigisha E, Salez N, Nanjebe D, et al. (2017) Aetiology and Outcomes of
Suspected Infections of the Central Nervous System in Children in Mbarara, Uganda. Scientific
Reports 7.
12. De Beaudrap P, Nabasumba C, Grandesso F, Turyakira E, Schramm B, et al. (2011) Heterogeneous
decrease in malaria prevalence in children over a six-year period in south-western Uganda. Malaria
journal 10: 132. https://doi.org/10.1186/1475-2875-10-132 PMID: 21592332
13. Cavallo J, Chardon H, Chidiac C, Choutet P, Courvalin P, et al. (2006) Comite´ de l’antibiogramme de la
socie´te´ Franc¸aise de Microbiologie. Communique´.
14. WorldHealthOrganization/CenterforDiseaseControl (2010) Basic Malaria Microscopy: Tutor’s guide:
World Health Organization.
15. MinistryOfHealth (2012) Uganda Clinical Guidelines 2012: National Guidelines for Management of
Common Conditions; MinistryofHealth, editor. Kampala.
Antimicrobial treatment practices for CNS infections in Ugandan children
PLOS ONE | https://doi.org/10.1371/journal.pone.0205316 October 9, 2018 11 / 12
16. Mathlouthi N, Al-Bayssari C, El Salabi A, Bakour S, Ben Gwierif S, et al. (2016) Carbapenemases and
extended-spectrum beta-lactamases producing Enterobacteriaceae isolated from Tunisian and Libyan
hospitals. J Infect Dev Ctries 10: 718–727. https://doi.org/10.3855/jidc.7426 PMID: 27482803
17. WHO (2014) Antimicrobial resistance: Global Report on Surveillance. Geneva http://apps.who.int/iris/
bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1 accessed 3/3/2017.
18. O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. (2009) Burden of disease caused by
Streptococcus pneumoniae in children younger than 5 years: global estimates. The Lancet 374: 893–
902.
19. Kisakye A, Makumbi I, Nansera D, Lewis R, Braka F, et al. (2009) Surveillance for Streptococcus pneu-
moniae meningitis in children aged< 5 years: implications for immunization in Uganda. Clinical Infec-
tious Diseases 48: S153–S161. https://doi.org/10.1086/596495 PMID: 19191611
20. Mudhune S, Wamae M, NetworkSurveillanceforPneumococcalDiseaseintheEastAfricanRegion (2009)
Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumo-
nia from the Network for Surveillance of Pneumococcal Disease in the East African Region. Clinical
Infectious Diseases 48: S147–S152. https://doi.org/10.1086/596494 PMID: 19191610
21. WorldHealthOrganization (2015) Guidelines for the treatment of malaria: World Health Organization.
22. Church J, Maitland K (2014) Invasive bacterial co-infection in African children with Plasmodium falcipa-
rum malaria: a systematic review. BMC medicine 12: 31. https://doi.org/10.1186/1741-7015-12-31
PMID: 24548672
23. Price EH, de Louvois J, Workman MR (2000) Antibiotics for Salmonella meningitis in children. Journal
of Antimicrobial Chemotherapy 46: 653–655. PMID: 11062183
24. Molyneux E, Walsh A, Phiri A, Molyneux M (1998) Acute bacterial meningitis in children admitted to the
Queen Elizabeth Central Hospital, Blantyre, Malawi in 1996–97. Tropical Medicine & International
Health 3: 610–618.
25. De Bruycker M, Van den Bergh R, Dahmane A, Khogali M, Schiavetti B, et al. (2013) Non-adherence to
standard treatment guidelines in a rural paediatric hospital in Sierra Leone. Public health action 3: 118–
124. https://doi.org/10.5588/pha.12.0060 PMID: 26393013
26. Sundararajan R, Mwanga-Amumpaire J, Adrama H, Tumuhairwe J, Mbabazi S, et al. (2015) Sociocul-
tural and structural factors contributing to delays in treatment for children with severe malaria: A qualita-
tive study in southwestern Uganda. The American journal of tropical medicine and hygiene 92: 933–
940. https://doi.org/10.4269/ajtmh.14-0784 PMID: 25802438
Antimicrobial treatment practices for CNS infections in Ugandan children
PLOS ONE | https://doi.org/10.1371/journal.pone.0205316 October 9, 2018 12 / 12
